Abstract:Background Adverse pregnancy outcomes, which can be caused by multiple factors, present a significant threat to the health of mothers and their babies. Cell‐free fetal DNA (cffDNA) from placental trophoblast cells might be able to reflect placental and fetal status. Previous studies have yielded controversial results regarding the association of FF or cffDNA with various adverse pregnancy outcomes. A previous study has attempted to systematically assess the association between low fetal fraction (FF) and adverse pregnancy outcomes, but it failed to perform quantitative analyses due to the few studies included. In the present study, we attempted to quantitatively assess the association of FF (or cffDNA) with adverse pregnancy outcomes and further analyze the causes of heterogeneity. Objectives To investigate the association of high/low FF or cffDNA with adverse pregnancy outcomes. Search Strategy We searched the databases of PubMed, Embase, Cochrane, and Web of Science from January 1, 1990, to June 15, 2022 in this meta‐analysis. Selection Criteria Studies on the relationships of adverse pregnancy outcomes in women with FF or cell free DNA were included. Non‐English literature was excluded. Data Collection and Analysis Data about pregnancy outcomes and cell free DNA were extracted and meta‐analyzed. Subgroup analysis was performed by different outcomes. Main Results There were 11 studies included involving 8280 participants. No significant heterogeneity was observed among the studies (I2 = 27%, 25%), and a fixed‐effect model was used for weighted quantitative analysis. The results revealed that the FF or cffDNA during pregnancy was significantly associated with adverse pregnancy outcomes in pregnant women (OR = 1.57, 95% CI [1.24, 1.99], P = 0.233). The overall incidence of the maternal adverse outcomes was 8% (95% CI: 5–13). Subgroup analysis of different outcomes showed an evident association between low FF or cffDNA and hypertensive disorders of pregnancy (HDP) (OR = 1.76, 95% CI [1.36, 2.27], P = 0.581). There was no evidence that the occurrence of spontaneous preterm birth (sPTB) and placental abnormality was associated with FF or cffDNA. No association was observed between low FF or cffDNA during pregnancy and adverse outcomes in fetuses (OR = 1.39, 95% CI [0.99, 1.94], P = 0.242). The overall incidence of adverse outcomes in fetuses was 8% (95% CI: 6–11). There were controversies over the association between high FF or cffDNA and HDP, and sPTB and small for gestational age infant, among different studies. Conclusions Pregnant women with low FF or cffDNA during the first or second trimester of pregnancy have an overall increased risk of adverse pregnancy outcomes, especially HDP. However, the association between FF and various pregnancy outcomes needs to be further explored by more prospective studies.

Correlation of Maternal Plasma Total Cell-Free DNA and Fetal DNA Levels with Short Term Outcome of First-Trimester Vaginal Bleeding.

Can Single Progesterone Concentration Predict Miscarriage in Early Pregnant Women with Threatened Miscarriage: a Systematic Review and Meta-Analysis

The Relationship Between Fetal DNA in Maternal Plasma and Preterm Labour

Diagnosis of fetal chromosomal aneuploidy by free fetal DNA in maternal plasma in the first trimester

[Correlation of Free Fetal DNA with Beta-Human Chorionin Gonadotropin in Circulation in Pregnant Women with High Risk of Down's Syndrome].

Role of Measuring the Concentration of Circulating Non-host fetal DNA of Pregnant Women Plasma in Premature Delivery

Association between the first and second trimester cell free DNA fetal fraction and spontaneous preterm birth

Feasibility Study of Using Fetal DNA in Maternal Plasma for Non‐invasive Prenatal Diagnosis

Quantitative Study of Cell-Free Fetal DNA-SRY Gene in Preterm Labour Maternal Plasma

Cell-free DNA Methylation and Transcriptomic Signature Prediction of Pregnancies with Adverse Outcomes

Fetal DNA in maternal plasma is elevated in pregnancies with aneuploid fetuses.

Predictive value of cervical fetal fibronectin in the first trimester pregnancy outcome of recurrent spontaneous abortion

Association Between Levels of Total Cell-Free DNA and Development of Preeclampsia—A Literature Review

Maternal serum disintegrin and metalloprotease protein-12 in early pregnancy as a potential marker of adverse pregnancy outcomes.

Study on the Relation Between Concentration of Circulating Non-Host Fetal DNA in Pregnant Women and Pre-Eclampsia

PAl-l, and D-dimer data in the diagnosis and treatment of recurrent abortion in pregnant Chinese women

A study examining the correlation between serum 25-OH-VitD levels, CD3-CD19+ B lymphocytes, and the risk of early spontaneous abortion in pregnant women

Association of fetal fraction and cell‐free fetal DNA with adverse pregnancy outcomes: A systematic review

The Clinical Significance Of Prethrombotic State T-Pa, Pal-L, And D-Dimer Data In The Diagnosis And Treatment Of Recurrent Abortion In Pregnant Chinese Women

Cell-free Fetal DNA in the Maternal Circulation Does Not Stem from the Transplacental Passage of Fetal Erythroblasts

Significant Correlation Between Maternal Body Mass Index at Delivery and in the Second Trimester, and Second Trimester Circulating Total Cell-Free DNA Levels.